Seacoast Banking Corporation of Florida And 6 Other Stocks Have High Sales Growth And An Above 3% Return on Equity

(VIANEWS) – Seacoast Banking Corporation of Florida (SBCF), United Community Banks (UCBI), Charles River Laboratories (CRL) are the highest sales growth and return on equity stocks on this list.

Here is a list of stocks with an above 5% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?

1. Seacoast Banking Corporation of Florida (SBCF)

73% sales growth and 7.3% return on equity

Seacoast Banking Corporation of Florida operates as the bank holding company for Seacoast National Bank that provides financial services to retail and commercial customers in Florida. It offers commercial and retail banking, wealth management, and mortgage services; and brokerage and annuity services. The company offers noninterest and interest-bearing demand deposit, money market, savings, and customer sweep accounts; time certificates of deposit; construction and land development, commercial and residential real estate, and commercial and financial loans; and consumer loans, including installment loans and revolving lines, as well as loans for automobiles, boats, and personal or family purposes. As of December 31, 2021, it had 54 branch and commercial lending offices. The company was founded in 1926 and is headquartered in Stuart, Florida.

Earnings Per Share

As for profitability, Seacoast Banking Corporation of Florida has a trailing twelve months EPS of $1.69.

PE Ratio

Seacoast Banking Corporation of Florida has a trailing twelve months price to earnings ratio of 19.7. Meaning, the purchaser of the share is investing $19.7 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 7.3%.

Sales Growth

Seacoast Banking Corporation of Florida’s sales growth is 71.2% for the current quarter and 73% for the next.

2. United Community Banks (UCBI)

25.6% sales growth and 10.43% return on equity

United Community Banks, Inc. operates as a bank holding company for the United Community Bank, a state-chartered bank that provides various banking products and services. The company accepts checking, savings, money market, negotiable order of withdrawal, time, and other deposit accounts, as well as certificates of deposit. Its loan products include commercial real estate, commercial and industrial, commercial construction, residential mortgage and construction, consumer direct loans, and indirect auto loans, as well as home equity lines of credits. The company also offers investment products; wealth management services comprising financial planning, customized portfolio management, and investment advice; trust services to manage fiduciary assets; insurance products, including life insurance, long-term care insurance, and tax-deferred annuities; reinsurance on a property insurance contract; and payment processing, merchant, wire transfer, private banking, and other financial services. It serves individuals, small businesses, mid-sized commercial businesses, and non-profit organizations. The company operates through 193 locations in Georgia, North Carolina, South Carolina, Tennessee, and Florida markets. United Community Banks, Inc. was founded in 1950 and is based in Blairsville, Georgia.

Earnings Per Share

As for profitability, United Community Banks has a trailing twelve months EPS of $2.33.

PE Ratio

United Community Banks has a trailing twelve months price to earnings ratio of 13.98. Meaning, the purchaser of the share is investing $13.98 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 10.43%.

Volume

Today’s last reported volume for United Community Banks is 281460 which is 47.63% below its average volume of 537516.

3. Charles River Laboratories (CRL)

13.7% sales growth and 17.87% return on equity

Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Assessment (DSA), and Manufacturing Solutions (Manufacturing). The RMS segment produces and sells rodent research model strains and purpose-bred rats and mice for use by researchers. This segment also provides a range of services to assist its clients in supporting the use of research models in research and screening non-clinical drug candidates, including research models, genetically engineered models and services, insourcing solutions, and research animal diagnostic services. The DSA segment offers early and in vivo discovery services for the identification and validation of novel targets, chemical compounds, and antibodies through delivery of non-clinical drug and therapeutic candidates ready for safety assessment; and safety assessment services, such as toxicology, pathology, safety pharmacology, bioanalysis, drug metabolism, and pharmacokinetics services. The Manufacturing segment provides in vitro methods for conventional and rapid quality control testing of sterile and non-sterile pharmaceuticals and consumer products. This segment also offers specialized testing of biologics that are outsourced by pharmaceutical and biotechnology companies; and avian vaccine services that provide specific-pathogen-free (SPF) fertile chicken eggs, SPF chickens, and diagnostic products used to manufacture vaccines. The company also provides contract vivarium operation services to biopharmaceutical clients. Charles River Laboratories International, Inc. was founded in 1947 and is headquartered in Wilmington, Massachusetts.

Earnings Per Share

As for profitability, Charles River Laboratories has a trailing twelve months EPS of $7.2.

PE Ratio

Charles River Laboratories has a trailing twelve months price to earnings ratio of 34.99. Meaning, the purchaser of the share is investing $34.99 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 17.87%.

Revenue Growth

Year-on-year quarterly revenue growth grew by 6.4%, now sitting on 3.69B for the twelve trailing months.

4. Park City Group (PCYG)

8.2% sales growth and 9.66% return on equity

Park City Group, Inc., a software-as-a-service provider, designs, develops, and markets proprietary software products in North America. The company offers ReposiTrak MarketPlace, a supplier discovery and B2B e-commerce solution; ReposiTrak Compliance and Food Safety solutions, which reduces potential regulatory and legal risk from their supply chain partners; and ReposiTrak Supply Chain solutions that enables customers to manage relationships with suppliers. It also provides ScoreTracker, Vendor Managed Inventory, Store Level Ordering and Replenishment, Enterprise Supply Chain Planning, Fresh Market Manager, and ActionManager supply chain solutions to manage inventory, product mix, and labor. In addition, the company offers business-consulting services to suppliers and retailers in the grocery, convenience store, and specialty retail industries, as well as professional consulting services. It primarily serves multi-store retail chains, wholesalers and distributors, and their suppliers. The company is headquartered in Murray, Utah.

Earnings Per Share

As for profitability, Park City Group has a trailing twelve months EPS of $0.2.

PE Ratio

Park City Group has a trailing twelve months price to earnings ratio of 30.65. Meaning, the purchaser of the share is investing $30.65 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 9.66%.

Revenue Growth

Year-on-year quarterly revenue growth grew by 3.5%, now sitting on 18.21M for the twelve trailing months.

5. Escalade (ESCA)

7% sales growth and 13.35% return on equity

Escalade, Incorporated, together with its subsidiaries, manufactures, distributes, imports, and sells sporting goods in North America, Europe, and internationally. The company provides various sporting goods brands in basketball goals, archery, indoor and outdoor game recreation, and fitness products. It offers archery products under the Bear Archery, Trophy Ridge, Whisker Biscuit, Cajun Bowfishing, Karnage, Fletcher, SIK, BearX, and Rocket brand names; table tennis products under the STIGA and Ping-Pong brands; basketball goals under the Goalrilla, Goaliath, Silverback, Hoopstar, and Goalsetter brand names; and pickleball under the Onix, DURA, and Pickleball Now brands. The company also provides play systems under the Woodplay, Jack & June, and Childlife brands; fitness products under the STEP, Lifeline, Kettleworx, Natural Fitness, and PER4M brand names; safety products under the USWeight brand; hockey and soccer game tables under the Triumph Sports, Atomic, American Legend, Air Hockey, and HJ Scott brands; and billiard tables and accessories under the American Heritage Billiards, Brunswick Billiards, Gold Crown, Centennial, Cue&Case, Lucasi, Mizerak, PureX, Rage, Players, Minnesota Fats, and Mosconi brand names. In addition, it offers darting products under the Unicorn, Winmau, Arachnid, Accudart, and Nodor brands; water sports products under the RAVE Sports brand; and outdoor game products under the Victory Tailgate, Triumph Sports, Zume Games, and Viva Sol brand names. The company provides its products through sporting goods retailers, specialty dealers, online retailers, traditional department stores, and mass merchants. Escalade, Incorporated was founded in 1922 and is headquartered in Evansville, Indiana.

Earnings Per Share

As for profitability, Escalade has a trailing twelve months EPS of $2.07.

PE Ratio

Escalade has a trailing twelve months price to earnings ratio of 6.13. Meaning, the purchaser of the share is investing $6.13 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 13.35%.

Sales Growth

Escalade’s sales growth is 5.4% for the current quarter and 7% for the next.

6. Ulta Beauty (ULTA)

6.6% sales growth and 60.94% return on equity

Ulta Beauty, Inc. operates as a retailer of beauty products in the United States. The company's stores offer cosmetics, fragrances, skincare and haircare products, bath and body products, and salon styling tools; professional hair products; salon services, including hair, skin, makeup, and brow services; and nail services. It also provides its private label products, such as the Ulta Beauty Collection branded cosmetics, skincare, and bath products, as well as Ulta Beauty branded products; and the Ulta Beauty branded gifts. It also distributes its products through its website ulta.com; and mobile applications. The company was formerly known as Ulta Salon, Cosmetics & Fragrance, Inc. and changed its name to Ulta Beauty, Inc. in January 2017. Ulta Beauty, Inc. was incorporated in 1990 and is based in Bolingbrook, Illinois.

Earnings Per Share

As for profitability, Ulta Beauty has a trailing twelve months EPS of $3.11.

PE Ratio

Ulta Beauty has a trailing twelve months price to earnings ratio of 168.65. Meaning, the purchaser of the share is investing $168.65 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 60.94%.

Revenue Growth

Year-on-year quarterly revenue growth grew by 17.2%, now sitting on 9.71B for the twelve trailing months.

Yearly Top and Bottom Value

Ulta Beauty’s stock is valued at $524.50 at 19:22 EST, below its 52-week high of $531.69 and way higher than its 52-week low of $330.80.

7. Clearwater Paper Corporation (CLW)

5.9% sales growth and 11.58% return on equity

Clearwater Paper Corporation produces and sells private label tissue and bleached paperboard products in the United States and internationally. The company operates through two segments, Consumer Products, and Pulp and Paperboard. The Consumer Products segment manufactures and sells a line of at-home tissue products, including bath tissues, paper towels, facial tissues, and napkins; recycled fiber value grade products; and away-from-home products and parent rolls. This segment sells its products to retailers and wholesale distributors, including grocery, drug, mass merchants, and discount stores. The Pulp and Paperboard segment manufactures and markets bleached paperboard, folding cartons, liquid packaging, cups and plates, blister and carded packaging, top sheet and commercial printing grades and softwood pulp products, as well as offers custom sheeting, slitting and cutting of paperboard. It sells its products to packaging converters, folding carton converters, merchants, and commercial printers. Clearwater Paper Corporation was incorporated in 2005 and is headquartered in Spokane, Washington.

Earnings Per Share

As for profitability, Clearwater Paper Corporation has a trailing twelve months EPS of $3.66.

PE Ratio

Clearwater Paper Corporation has a trailing twelve months price to earnings ratio of 10.1. Meaning, the purchaser of the share is investing $10.1 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 11.58%.

Revenue Growth

Year-on-year quarterly revenue growth grew by 19.6%, now sitting on 2.04B for the twelve trailing months.

Leave a Reply

Your email address will not be published. Required fields are marked *